Ironwood Pharmaceuticals (IRWD) Current Deferred Revenue (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Current Deferred Revenue of $1.5 million for Q1 2026, up 32.97% sequentially from $1.1 million in Q4 2025, and down 18.04% YoY from $1.8 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Current Deferred Revenue for 15 years, with the latest figure at $1.5 million in Q1 2026.
- Quarterly Current Deferred Revenue fell 18.04% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 18.04% YoY) and the FY2025 annual result came in at $1.1 million, down 45.52% from the prior year.
- Current Deferred Revenue rose to $1.5 million in Q1 2026 per IRWD's latest filing, from $1.1 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $2.6 million in Q4 2023 and troughed at $978000.0 in Q2 2025.
- A 4-year average of $1.6 million and a median of $1.5 million in 2026 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2025 and 2026: Current Deferred Revenue slumped 45.52% in 2025, then declined 18.04% in 2026.
- Over 4 years, Current Deferred Revenue stood at $2.6 million in 2023, then retreated by 22.44% to $2.0 million in 2024, then slumped by 45.52% to $1.1 million in 2025, then soared by 32.97% to $1.5 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $1.5 million, $1.1 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Ironwood Pharmaceuticals | 676.53 Mn | 597.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25 Mn |
| Mar 31, 2026 | 1.47 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 978,000.00 |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2020 | 875,000.00 |
| Jun 30, 2020 | 875,000.00 |
| Mar 31, 2020 | 875,000.00 |
| Dec 31, 2019 | 900,000.00 |
| Sep 30, 2019 | 1.28 Mn |
| Dec 31, 2018 | 252,000.00 |
| Sep 30, 2018 | 247,000.00 |
| Jun 30, 2018 | 242,000.00 |
| Mar 31, 2018 | 237,000.00 |
| Dec 31, 2017 | 195,000.00 |
| Sep 30, 2017 | 195,000.00 |
| Jun 30, 2017 | 225,000.00 |